Virtual Network's Login.
ESH Gold Institutional Partner
ESH Gold Institutional Partner
ESH Gold Institutional Partner
ABOUT THE CONFERENCE
An outstanding faculty of myeloma experts will present the most recent advances and perspectives in the field of plasma disorders from pathophysiology to diagnosis and therapy.
The plenary conference program is designed to place emphasis on leading-edge basic and clinical research. The presentation of unpublished data is encouraged. Ample time is deliberately provided for in-depth scientific discussion and interaction.
Registered participants will further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in the field, including during small Meet the Expert sessions and Mentored Posters Walks. Registered participants are invited to submit their biology and clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.
CONFERENCE MAIN SCIENTIFIC TOPICS:
• MGUS
• Smouldering myeloma
• Characterising multiple myeloma
• Newly-diagnosed fit multiple myeloma
• Role of frailty for treatment decisions
• Personalising treatment in multiple myeloma
• Relapsed multiple myeloma
• Novel technologies for tailored treatment
• Amyloidosis and Weldenstrom’s Disease
LEARNING OBJECTIVES
• Update on the pathophysiology of MGUS, SMM and myeloma
• Update on the diagnostic criteria and the use of new assessments
• Treatment of fit myeloma patients
• Treatment of frail myeloma patients
• Optimal sequencing at early and late relapse
• The role of new immunotherapy approaches
• Role of novel drugs
• Novel technologies for tailored treatment
• Latest updates in other plasma cell disorders beyond myeloma
THE PROGRAMME WILL INCLUDE:
Plenary Sessions – Panel Discussions – Debates – Simultaneous Meet the Expert Sessions Poster Walks
Brief Oral Communications – Ample time for in-depth discussion
Abstracts are eligible for brief oral communications or poster presentations.
Deadline: January 5th, 2026
